[For a better control of placental tumors].
D001932:Brain Neoplasms / Q000175:diagnosis; D002822:Choriocarcinoma / Q000188:drug therapy / Q000517:prevention & control*; D006063:Chorionic Gonadotropin / Q000097:blood; D003609:Dactinomycin / Q000627:therapeutic use; D005260:Female; D005602:France; D006801:Humans; D006828:Hydatidiform Mole / Q000517:prevention & control*; D007044:Hysterectomy; D008175:Lung Neoplasms / Q000601:surgery; D007986:Luteinizing Hormone / Q000097:blood; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D011247:Pregnancy; D011314:Preventive Health Services; D011379:Prognosis; D014750:Vincristine / Q000627:therapeutic use
D006063:Chorionic Gonadotropin; D003609:Dactinomycin; D014750:Vincristine; D007986:Luteinizing Hormone; D008727:Methotrexate
Pour un meilleur contrôle des tumeurs placentaires